Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15188)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2015 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Eliades M, Spyrou E. Vitamin D: A new player in non-alcoholic fatty liver disease? World J Gastroenterol 2015; 21(6): 1718-1727 [PMID: 25684936 DOI: 10.3748/wjg.v21.i6.1718] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i6/1718.htm |
| Number | Citing Articles |
| 1 |
Mojgan Morvaridzadeh, Seyed Mostafa Nachvak, Reza Mohammadi, Shima Moradi, Roghayeh Mostafai, Ana Beatriz Pizarro, Hadi Abdollahzad. Probiotic Yogurt Fortified with Vitamin D Can Improve Glycemic Status in Non-Alcoholic Fatty Liver Disease Patients: a Randomized Clinical Trial. Clinical Nutrition Research 2021; 10(1): 36 doi: 10.7762/cnr.2021.10.1.36
|
| 2 |
Doha Reda, Gehad E. Elshopakey, Talat A. Albukhari, Samah J. Almehmadi, Bassem Refaat, Engy F. Risha, Hebatallah A. Mahgoub, Mohamed E. El-Boshy, Fatma M. Abdelhamid. Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c/ PPARα-NF-κB/IR-S2 signaling pathway. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1164512
|
| 3 |
Eva Gatineau, Frédéric Capel, Dominique Dardevet, Jérémie David, Corinne Pouyet, Sergio Polakof, Laurent Mosoni. Effect of high chronic intake of sucrose on liver metabolism in aging rats. Modulation by rutin and micronutrients. Journal of Physiology and Biochemistry 2018; 74(4): 569 doi: 10.1007/s13105-018-0628-y
|
| 4 |
Mohamed El-Sherbiny, Mohamed Eldosoky, Mohamed El-Shafey, Gamal Othman, Hany A. Elkattawy, Tamer Bedir, Nehal Mohsen Elsherbiny. Vitamin D nanoemulsion enhances hepatoprotective effect of conventional vitamin D in rats fed with a high-fat diet. Chemico-Biological Interactions 2018; 288: 65 doi: 10.1016/j.cbi.2018.04.010
|
| 5 |
|
| 6 |
Eunjung Park, Eun Young Park. Inverse Association between Serum 25-hydroxyvitamin D Levels and Risk of Suspected Non-Alcoholic Fatty Liver Disease in Obese Population. International Journal of Environmental Research and Public Health 2021; 18(16): 8682 doi: 10.3390/ijerph18168682
|
| 7 |
A. Drori, D. Rotnemer-Golinkin, S. Avni, A. Drori, O. Danay, D. Levanon, J. Tam, L. Zolotarev, Y. Ilan. Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0688-4
|
| 8 |
Madalena Von-Hafe, Marta Borges-Canha, Catarina Vale, Ana Rita Leite, João Sérgio Neves, Davide Carvalho, Adelino Leite-Moreira. Nonalcoholic Fatty Liver Disease and Endocrine Axes—A Scoping Review. Metabolites 2022; 12(4): 298 doi: 10.3390/metabo12040298
|
| 9 |
Ilaria Barchetta, Flavia Cimini, Maria Cavallo. Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future. Nutrients 2017; 9(9): 1015 doi: 10.3390/nu9091015
|
| 10 |
Yuxiong Chen, Siqin Feng, Zhen’ge Chang, Yakun Zhao, Yanbo Liu, Jia Fu, Yijie Liu, Siqi Tang, Yitao Han, Shuyang Zhang, Zhongjie Fan. Higher Serum 25-Hydroxyvitamin D Is Associated with Lower All-Cause and Cardiovascular Mortality among US Adults with Nonalcoholic Fatty Liver Disease. Nutrients 2022; 14(19): 4013 doi: 10.3390/nu14194013
|
| 11 |
Newaz Hossain, Pushpjeet Kanwar, Smruti R. Mohanty. A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/7109270
|
| 12 |
David R. Fraser. Vitamin D Deficiency and Energy Metabolism. Endocrinology 2015; 156(6): 1933 doi: 10.1210/en.2015-1298
|
| 13 |
Ramiar K. Kheder, James Hobkirk, Cordula M. Stover. In vitro Modulation of the LPS-Induced Proinflammatory Profile of Hepatocytes and Macrophages- Approaches for Intervention in Obesity?. Frontiers in Cell and Developmental Biology 2016; 4 doi: 10.3389/fcell.2016.00061
|
| 14 |
Salam Bennouar, Abdelghani Bachir Cherif, Amel Kessira, Djamel Eddine Bennouar, Samia Abdi. Association and interaction between vitamin D level and metabolic syndrome for non-alcoholic fatty liver disease. Journal of Diabetes & Metabolic Disorders 2021; 20(2): 1309 doi: 10.1007/s40200-021-00857-5
|
| 15 |
Stefan Pilz, Csilla Putz-Bankuti, Martin Gaksch, Walter Spindelboeck, Marius Haselberger, Florian Rainer, Andreas Posch, Philipp Kreuzer, Tatjana Stojakovic, Vanessa Stadlbauer, Barbara Obermayer-Pietsch, Rudolf Stauber. Effects of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentrations in Cirrhotic Patients: A Randomized Controlled Trial. Nutrients 2016; 8(5): 278 doi: 10.3390/nu8050278
|
| 16 |
O. M. Drapkina, R. N. Shepel, A. V. Starodubova, Yu. V. Evsutina. The main approaches to dietary changes in non-alcoholic fatty liver disease. Profilakticheskaya meditsina 2018; 21(6): 78 doi: 10.17116/profmed20182106178
|
| 17 |
Vanessa Rausch, Johannes Mueller, Sebastian Mueller. Liver Elastography. 2020; : 277 doi: 10.1007/978-3-030-40542-7_27
|
| 18 |
Cristin Grant. A vitamin D protocol post‐liver transplantation. Journal of the American Association of Nurse Practitioners 2017; 29(11): 658 doi: 10.1002/2327-6924.12503
|
| 19 |
Jaividhya Dasarathy, Rony Varghese, Abram Feldman, Amer Khiyami, Arthur J McCullough, Srinivasan Dasarathy. Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation. The Journal of Nutrition 2017; 147(10): 1938 doi: 10.3945/jn.117.254292
|
| 20 |
Elisabete Martins, Ana Oliveira. NAFLD and cardiovascular disease. Porto Biomedical Journal 2018; 3(2): e2 doi: 10.1016/j.pbj.0000000000000002
|
| 21 |
Andresa Renata Alves SÁ, Cristiane Pereira da SILVA, Ana Célia Oliveira dos SANTOS. VITAMINA D NO TRATAMENTO DE ESTEATO-HEPATITE NÃO-ALCOÓLICA: UMA REVISÃO INTEGRATIVA. UNIFUNEC CIENTÍFICA MULTIDISCIPLINAR 2022; 11(13): 1 doi: 10.24980/ucm.v11i13.5628
|
| 22 |
Ilaria Barchetta, Flavia Agata Cimini, Maria Gisella Cavallo. Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update. Nutrients 2020; 12(11): 3302 doi: 10.3390/nu12113302
|
| 23 |
Ningjian Wang, Hualing Zhai, Chaoxia Zhu, Qin Li, Bing Han, Yi Chen, Chunfang Zhu, Yingchao Chen, Fangzhen Xia, Dongping Lin, Yingli Lu. Combined Association of Vitamin D and Sex Hormone Binding Globulin With Nonalcoholic Fatty Liver Disease in Men and Postmenopausal Women. Medicine 2016; 95(4): e2621 doi: 10.1097/MD.0000000000002621
|
| 24 |
Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, Niki Katsiki, Dimitri P. Mikhailidis, Peter P. Toth, Ioanna Gouni-Berthold, John Mancini, David Marais, Patrick Moriarty, Massimiliano Ruscica, Amirhossein Sahebkar, Dragos Vinereanu, Arrigo Francesco Giuseppe Cicero, Maciej Banach, Julio Acosta, Mutaz Al-Khnifsawi, Fahad Alnouri, Fahma Amar, Atanas G. Atanasov, Gani Bajraktari, Maciej Banach, Ioanna Gouni-Berthold, Sonu Bhaskar, Agata Bielecka-Dąbrowa, Bojko Bjelakovic, Eric Bruckert, Ibadete Bytyçi, Alberto Cafferata, Richard Ceska, Arrigo F.G. Cicero, Krzysztof Chlebus, Xavier Collet, Magdalena Daccord, Olivier Descamps, Dragan Djuric, Ronen Durst, Marat V. Ezhov, Zlatko Fras, Dan Gaita, Ioanna Gouni-Berthold, Adrian V. Hernandez, Steven R. Jones, Jacek Jozwiak, Nona Kakauridze, Amani Kallel, Niki Katsiki, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martinez, Mohsen Mazidi, Dimitri P. Mikhailidis, Erkin Mirrakhimov, Andre R. Miserez, Olena Mitchenko, Natalya P. Mitkovskaya, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Peter E. Penson, Zaneta Petrulioniene, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Dina Radenkovic, Michał Rakowski, Jemaa Riadh, Dimitri Richter, Manfredi Rizzo, Massimiliano Ruscica, Amirhossein Sahebkar, Maria-Corina Serban, Abdullah M.A Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Peter P. Toth, Margus Viigimaa, Pedro Valdivielso, Dragos Vinereanu, Branislav Vohnout, Stephan von Haehling, Michal Vrablik, Nathan D. Wong, Hung-I Yeh, Jiang Zhisheng, Andreas Zirlik. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP). Pharmacological Research 2023; 189: 106679 doi: 10.1016/j.phrs.2023.106679
|
| 25 |
Xiao-fei Guo, Chong Wang, Ting Yang, Shan Li, Ke-lei Li, Duo Li. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Food & Function 2020; 11(9): 7389 doi: 10.1039/D0FO01095B
|
| 26 |
Gyu Hee Kim, Hyeon-Ju Jeong, Yoo Jeong Lee, Hyeon Young Park, Soo Kyung Koo, Joo Hyun Lim. Vitamin D ameliorates age-induced nonalcoholic fatty liver disease by increasing the mitochondrial contact site and cristae organizing system (MICOS) 60 level. Experimental & Molecular Medicine 2024; 56(1): 142 doi: 10.1038/s12276-023-01125-7
|
| 27 |
Brandon Perumpail, Andrew Li, Nimy John, Sandy Sallam, Neha Shah, Waiyee Kwong, George Cholankeril, Donghee Kim, Aijaz Ahmed. The Role of Vitamin E in the Treatment of NAFLD. Diseases 2018; 6(4): 86 doi: 10.3390/diseases6040086
|
| 28 |
Jeniffer Danielle M. Dutra, Quelson Coelho Lisboa, Silvia Marinho Ferolla, Carolina Martinelli M. L. Carvalho, Camila Costa M. Mendes, Teresa Cristina A. Ferrari, Cláudia Alves Couto. Vitamin D levels are not associated with non-alcoholic fatty liver disease severity in a Brazilian population. International Journal for Vitamin and Nutrition Research 2021; 91(5-6): 411 doi: 10.1024/0300-9831/a000667
|
| 29 |
Qinwei Yu, Zhenzhou Jiang, Luyong Zhang. Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease. Pharmacology & Therapeutics 2018; 190: 81 doi: 10.1016/j.pharmthera.2018.04.005
|
| 30 |
|
| 31 |
Omar Hegazi, Samer Alalalmeh, Moyad Shahwan, Ammar Jairoun, Mansour Alourfi, Ghfran Bokhari, Abdullah Alkhattabi, Saeed Alsharif, Mohannad Aljehani, Abdulmalik Alsabban, Mohammad Almtrafi, Ysear Zakri, Abdullah AlMahmoud, Khalid Alghamdi, Ahmed Ashour, Nasser Alorfi. Exploring Promising Therapies for Non-Alcoholic Fatty Liver Disease: A ClinicalTrials.gov Analysis. Diabetes, Metabolic Syndrome and Obesity 2024; : 545 doi: 10.2147/DMSO.S448476
|
| 32 |
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
|
| 33 |
Stephanie Breher-Esch, Nishika Sahini, Anna Trincone, Christin Wallstab, Jürgen Borlak. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease. BMC Medical Genomics 2018; 11(1) doi: 10.1186/s12920-018-0438-7
|
| 34 |
Maher N. Ibrahim, Abeer A. Khalifa, Dalia A. Hemead, Amira Ebrahim Alsemeh, Marwa A. Habib. 1,25-Dihydroxycholecalciferol down-regulates 3-mercaptopyruvate sulfur transferase and caspase-3 in rat model of non-alcoholic fatty liver disease. Journal of Molecular Histology 2023; 54(2): 119 doi: 10.1007/s10735-023-10118-9
|
| 35 |
Lucia Pacifico, John F. Osborn, Enea Bonci, Pasquale Pierimarchi, Claudio Chiesa. Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables. Mini-Reviews in Medicinal Chemistry 2019; 19(4): 310 doi: 10.2174/1389557518666181025153712
|
| 36 |
Robert J. Wong, Nandita Kachru, Diane J. Martinez, Meghan Moynihan, A. Burak Ozbay, Stuart C. Gordon. Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases. Journal of Clinical Gastroenterology 2021; 55(10): 891 doi: 10.1097/MCG.0000000000001409
|
| 37 |
Soraiya Ebrahimpour-Koujan, Amir Ali Sohrabpour, Farshad Foroughi, Ehsan Alvandi, Ahmad Esmaillzadeh. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial. Trials 2019; 20(1) doi: 10.1186/s13063-019-3241-7
|
| 38 |
Jacques Delarue, Jean‐Paul Lallès. Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long‐chain n‐3 PUFA. Molecular Nutrition & Food Research 2016; 60(1): 147 doi: 10.1002/mnfr.201500346
|
| 39 |
Nima Motamed, Mansooreh Maadi, Masoudreza Sohrabi, Hossein Keyvani, Hossein Poustchi, Farhad Zamani. Rural Residency has a Protective Effect and Marriage is a Risk Factor for NAFLD. Hepatitis Monthly 2016; 16(7) doi: 10.5812/hepatmon.38357
|
| 40 |
Marta Borges-Canha, João Sérgio Neves, Fernando Mendonça, Maria Manuel Silva, Cláudia Costa, Pedro M Cabral, Vanessa Guerreiro, Rita Lourenço, Patrícia Meira, Daniela Salazar, Maria João Ferreira, Jorge Pedro, Ana Rita Leite, Madalena von-Hafe, Catarina Vale, Sara Viana, Ana Sande, Sandra Belo, Eva Lau, Paula Freitas, Davide Carvalho. The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 487 doi: 10.2147/DMSO.S286334
|
| 41 |
SalmaY H Shakour, RamezAbd-Elmoneim Barhoma, Nahid MEL-Fateh Tahoon, RomysaaA ELshrbiny. Study on the effect of vitamin D on obesity and fatty liver induced by monosodium glutamate in male albino rats. Tanta Medical Journal 2022; 50(2): 125 doi: 10.4103/tmj.tmj_75_21
|
| 42 |
Arrigo Cicero, Alessandro Colletti, Stefano Bellentani. Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence. Nutrients 2018; 10(9): 1153 doi: 10.3390/nu10091153
|
| 43 |
Ahmed Fayed, Mahmoud M. El Nokeety, Ahmed A. Heikal, Khaled M. Sadek, Hany Hammad, Dina O. Abdulazim, Mona M. Salem, Usama A. Sharaf El Din. Urine albumin and serum uric acid are important determinants of serum 25 hydroxyvitamin D level in pre-dialysis chronic kidney disease patients. Renal Failure 2019; 41(1): 540 doi: 10.1080/0886022X.2018.1563552
|
| 44 |
E. Cipponeri, N. Vitturi, V. Mariano, F. Boscari, S. Galasso, C. Crepaldi, G. P. Fadini, S. Vigili de Kreutzenberg, M. C. Marescotti, E. Iori, F. Cavallin, L. Sartori, A. Baritussio, A. Avogaro, D. Bruttomesso. Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes. Journal of Endocrinological Investigation 2019; 42(9): 1099 doi: 10.1007/s40618-019-01031-8
|
| 45 |
Maria Luger, Renate Kruschitz, Christian Kienbacher, Stefan Traussnigg, Felix B. Langer, Karin Schindler, Tanja Würger, Friedrich Wrba, Michael Trauner, Gerhard Prager, Bernhard Ludvik. Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency. Obesity Surgery 2016; 26(10): 2425 doi: 10.1007/s11695-016-2123-2
|
| 46 |
Antonio Olveira, Pedro Herranz, María Luisa Montes. Psoriasis and fatty liver: a harmful synergy. Revista Española de Enfermedades Digestivas 2019; 111: 314 doi: 10.17235/reed.2019.6263/2019
|
| 47 |
Tian Liu, Lei Xu, Fu-Hua Chen, Yi-Bo Zhou. Association of serum vitamin D level and nonalcoholic fatty liver disease: a meta-analysis. European Journal of Gastroenterology & Hepatology 2020; 32(2): 140 doi: 10.1097/MEG.0000000000001486
|
| 48 |
Elia Balestra, Arianna Traunero, Egidio Barbi. Investigating the role of Vitamin D in NAFLD: is liver biopsy justifiable in children?. European Journal of Pediatrics 2022; 181(11): 3985 doi: 10.1007/s00431-022-04598-2
|
| 49 |
Elaine Shehata, Rehan Qayyum. The Effect of Serum Vitamin D on Serum ALT Levels in Healthy Individuals. Journal of Clinical Gastroenterology 2016; 50(9): e81 doi: 10.1097/MCG.0000000000000459
|
| 50 |
Laura Taban, Dana Stoian, Bogdan Timar, Daniela Amzar, Calin Adela, Alexandru Motofelea, Andreea Borlea, Romain Frisoni, Nadege Laguerre. Vitamin D Status and Steatohepatitis in Obese Diabetic and Non-Diabetic Patients. Journal of Clinical Medicine 2022; 11(18): 5482 doi: 10.3390/jcm11185482
|
| 51 |
Xueqi Li, Chi Pan, Wenjun Ma, Ting Yang, Chong Wang, Weiwei Han, Wei Zhang, Hui Li, Zhongxia Li, Ting Zhao, Xiao-fei Guo, Duo Li. Effects of dietary supplementation of fish oil plus vitamin D3 on gut microbiota and fecal metabolites, and their correlation with nonalcoholic fatty liver disease risk factors: a randomized controlled trial. Food & Function 2024; 15(5): 2616 doi: 10.1039/D3FO02319B
|
| 52 |
Ji-Juan Zhang, Han-Cheng Yu, Yue Li, Yan-Bo Zhang, Ting-Ting Geng, Qi Lu, Yun-Fei Liao, Kun-Quan Guo, Liang Du, Hua-Ling Ruan, Kun Yang, Gang Liu, An Pan. Association between serum 25-hydroxy vitamin D concentrations and mortality among individuals with metabolic dysfunction–associated fatty liver disease: a prospective cohort study. The American Journal of Clinical Nutrition 2022; 116(5): 1409 doi: 10.1093/ajcn/nqac260
|
| 53 |
Alper Sonmez, Cemal Nuri Ercin, Mustafa Cesur, Teoman Dogru. Nutraceuticals and Cardiovascular Disease. Contemporary Cardiology 2021; : 141 doi: 10.1007/978-3-030-62632-7_9
|
| 54 |
S.M. Tkach, V.I. Pankiv, A.E. Dorofeev. Relationship between serum 25-hydroxyvitamine D and non-alcoholic fatty liver disease. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2023; 19(3): 194 doi: 10.22141/2224-0721.19.3.2023.1271
|
| 55 |
Maria Luger, Renate Kruschitz, Christian Kienbacher, Stefan Traussnigg, Felix B. Langer, Gerhard Prager, Karin Schindler, Enikö Kallay, Friedrich Hoppichler, Michael Trauner, Michael Krebs, Rodrig Marculescu, Bernhard Ludvik. Vitamin D3 Loading Is Superior to Conventional Supplementation After Weight Loss Surgery in Vitamin D-Deficient Morbidly Obese Patients: a Double-Blind Randomized Placebo-Controlled Trial. Obesity Surgery 2017; 27(5): 1196 doi: 10.1007/s11695-016-2437-0
|
| 56 |
Yang Xia, Qijun Wu, Huixu Dai, Jiale Lv, Yashu Liu, Hui Sun, Yuting Jiang, Qing Chang, Kaijun Niu, Yuhong Zhao. Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 Participants. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.642509
|
| 57 |
Ioanna Aggeletopoulou, Konstantinos Thomopoulos, Athanasia Mouzaki, Christos Triantos. Vitamin D–VDR Novel Anti-Inflammatory Molecules—New Insights into Their Effects on Liver Diseases. International Journal of Molecular Sciences 2022; 23(15): 8465 doi: 10.3390/ijms23158465
|
| 58 |
Wenwen Li, Li Zhang, Yuanling Liu, Chunyan Wang, Yijing Long, Zhixin Huang, Yuanping Han, Yixiang Duan. Metabolite profiling of mice under long-term fructose drinking and vitamin D deficiency: increased risks for metabolic syndrome and nonalcoholic fatty liver disease. Journal of Physiology and Biochemistry 2020; 76(4): 587 doi: 10.1007/s13105-020-00764-y
|
| 59 |
Jacques Delarue, Jean-Paul Lallès. Rôles de l’intestin et du foie dans la progression de la stéatopathie métabolique et sa modulation par les acides gras polyinsaturés à longue chaîne n-3. Cahiers de Nutrition et de Diététique 2016; 51(6): 283 doi: 10.1016/j.cnd.2016.09.002
|
| 60 |
Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(31): 7006-7016 doi: 10.3748/wjg.v22.i31.7006
|
| 61 |
Toshihiro Umehara, Giovanni Targher. Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults. PLOS ONE 2018; 13(6): e0197900 doi: 10.1371/journal.pone.0197900
|
| 62 |
Li-Wei Chen, Cheng-Hung Chien, Sheng-Fong Kuo, Chia-Ying Yu, Chih-Lang Lin, Rong-Nan Chien. Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: a community-based study. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1040-y
|
| 63 |
Nghiem Xuan Hoan, Hoang Van Tong, Le Huu Song, Christian G Meyer, Thirumalaisamy P Velavan. Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review. World Journal of Gastroenterology 2018; 24(4): 445-460 doi: 10.3748/wjg.v24.i4.445
|
| 64 |
Samar R. El Khoudary, Saad Samargandy, Irfan Zeb, Temitope Foster, Ian H. de Boer, Dong Li, Matthew J. Budoff. Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort. Nutrition, Metabolism and Cardiovascular Diseases 2020; 30(1): 114 doi: 10.1016/j.numecd.2019.09.004
|
| 65 |
Suxia Hu, Abdusemer Reyimu. Vitamin D Improves the Lipotoxicity of Liver Cells by Adjusting Epigenetic Characteristics of Genes. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-133758
|
| 66 |
Aunchalee Jaroenlapnopparat, Thanitsara Rittiphairoj, Natapat Chaisidhivej, Bradley Walker, Nipith Charoenngam. High parathyroid hormone level as a marker of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2023; 17(8): 102827 doi: 10.1016/j.dsx.2023.102827
|
| 67 |
Zeeshan Javed, Maria Papageorgiou, Harshal Deshmukh, Eric Kilpatrick, Vincent Mann, Lynsey Corless, George Abouda, Alan Rigby, Stephen Atkin, Thozhukat Sathyapalan. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. Nutrients 2019; 11(1): 188 doi: 10.3390/nu11010188
|
| 68 |
Maria Del Ben, Licia Polimeni, Francesco Baratta, Daniele Pastori, Francesco Angelico. The role of nutraceuticals for the treatment of non‐alcoholic fatty liver disease. British Journal of Clinical Pharmacology 2017; 83(1): 88 doi: 10.1111/bcp.12899
|
| 69 |
Alessandro Federico, Marcello Dallio, Giuseppe Caprio, Antonietta Gravina, Desiree Picascia, Mario Masarone, Marcello Persico, Carmela Loguercio. Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis. Nutrients 2017; 9(10): 1074 doi: 10.3390/nu9101074
|
| 70 |
Payam Sharifan, Susan Darroudi, Mahdi Rafiee, Kiarash Roustai Geraylow, Romina Hemmati, Mohammad Rashidmayvan, Mohamad Safarian, Saeid Eslami, Hassan Vatanparast, Reza Zare-Feizabadi, Maryam Mohammadi-Bjgiran, Hamideh Ghazizadeh, Zahra Khorasanchi, Mohammad Bagherniya, Gordon Ferns, Mitra Rezaie, Majid Ghayour-Mobarhan. The effects of low-fat dairy products fortified with 1500 IU vitamin D3 on serum liver function biomarkers in adults with abdominal obesity: a randomized controlled trial. Journal of Health, Population and Nutrition 2023; 42(1) doi: 10.1186/s41043-023-00401-6
|
| 71 |
Hamidreza Tavakoli, Hossein Rostami, Amir Avan, Mohammad Bagherniya, Gordon A. Ferns, Sayyed Saeid Khayyatzadeh, Majid Ghayour‐Mobarhan. High dose vitamin D supplementation is associated with an improvement in serum markers of liver function. BioFactors 2019; 45(3): 335 doi: 10.1002/biof.1496
|
| 72 |
Jeanette Irene Christiene Manoppo, Vivekenanda Pateda, Cindy Prayogo, Fima L. F. G. Langi, Fahrul Nurkolis, Apollinaire Tsopmo. Relationships of 25-hydroxyvitamin D levels and non-alcoholic fatty liver disease in obese children: A possible strategy to promote early screening of NAFLD. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1025396
|
| 73 |
Ming Ma, Qi Long, Fei Chen, Ting Zhang, Wenqiao Wang. Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model. Clinics and Research in Hepatology and Gastroenterology 2020; 44(4): 513 doi: 10.1016/j.clinre.2019.10.007
|
| 74 |
Rong Jiang, Yichao Zhou, Lei Han, Zhen Hong. Serum vitamin D is associated with ultrasound-defined hepatic fibrosis. Clinics and Research in Hepatology and Gastroenterology 2023; 47(10): 102228 doi: 10.1016/j.clinre.2023.102228
|
| 75 |
Abraham Neelankal John, Fang-Xu Jiang. An overview of type 2 diabetes and importance of vitamin D3-vitamin D receptor interaction in pancreatic β-cells. Journal of Diabetes and its Complications 2018; 32(4): 429 doi: 10.1016/j.jdiacomp.2017.12.002
|
| 76 |
Arash Ziaee, Ghodsiyeh Azarkar, Masood Ziaee. Role of fatty liver in coronavirus disease 2019 patients’ disease severity and hospitalization length: a case–control study. European Journal of Medical Research 2021; 26(1) doi: 10.1186/s40001-021-00590-y
|
| 77 |
Priscila Silva Figueiredo, Aline Inada, Melina Ribeiro Fernandes, Daniela Granja Arakaki, Karine Freitas, Rita Avellaneda Guimarães, Valter Aragão do Nascimento, Priscila Aiko Hiane. An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease. Molecules 2018; 23(4): 877 doi: 10.3390/molecules23040877
|
| 78 |
Zumin Shi, Wenying Chen, Anne Taylor, Alastair Burt. Elevated transaminase levels among overweight adolescents in eastern China. Acta Paediatrica 2016; 105(12) doi: 10.1111/apa.13521
|
| 79 |
Fariborz Mansour-Ghanaei, Makan Pourmasoumi, Amir Hadi, Nahid Ramezani-Jolfaie, Farahnaz Joukar. The Efficacy of Vitamin D Supplementation against Nonalcoholic Fatty Liver Disease: A Meta-Analysis. Journal of Dietary Supplements 2020; 17(4): 467 doi: 10.1080/19390211.2019.1624671
|
| 80 |
Alexandra Marziou, Clothilde Philouze, Charlène Couturier, Julien Astier, Philippe Obert, Jean-François Landrier, Catherine Riva. Vitamin D Supplementation Improves Adipose Tissue Inflammation and Reduces Hepatic Steatosis in Obese C57BL/6J Mice. Nutrients 2020; 12(2): 342 doi: 10.3390/nu12020342
|
| 81 |
Brandon J. Perumpail, Rosann Cholankeril, Eric R. Yoo, Donghee Kim, Aijaz Ahmed. An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease. Diseases 2017; 5(4): 23 doi: 10.3390/diseases5040023
|
| 82 |
Behnam Saberi, Alia S Dadabhai, Julie Nanavati, Lin Wang, Russell T Shinohara, Gerard E Mullin. Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data. World Journal of Hepatology 2018; 10(1): 142-154 doi: 10.4254/wjh.v10.i1.142
|
| 83 |
Su-bin Lee, Mi Hyeon Jin, Jeong-Hyun Yoon. The contribution of vitamin D insufficiency to the onset of steatotic liver disease among individuals with metabolic dysfunction. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-57380-9
|
| 84 |
Christopher Beal, Ashraf Gorgey, Pamela Moore, Nathan Wong, Robert A. Adler, David Gater. Higher dietary intake of vitamin D may influence total cholesterol and carbohydrate profile independent of body composition in men with Chronic Spinal Cord Injury. The Journal of Spinal Cord Medicine 2018; 41(4): 459 doi: 10.1080/10790268.2017.1361561
|
| 85 |
Flavia A Cimini, Ilaria Barchetta, Simone Carotti, Laura Bertoccini, Marco G Baroni, Umberto Vespasiani-Gentilucci, Maria-Gisella Cavallo, Sergio Morini. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(19): 3407-3417 doi: 10.3748/wjg.v23.i19.3407
|
| 86 |
Nasrin Sharifi, Reza Amani. Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials. Critical Reviews in Food Science and Nutrition 2019; 59(4): 693 doi: 10.1080/10408398.2017.1389693
|
| 87 |
Xiao-fei Guo, Chong Wang, Ting Yang, Wen-jun Ma, Jie Zhai, Ting Zhao, Tong-cheng Xu, Jun Li, He Liu, Andrew J. Sinclair, Duo Li. The effects of fish oil plus vitamin D3 intervention on non-alcoholic fatty liver disease: a randomized controlled trial. European Journal of Nutrition 2022; 61(4): 1931 doi: 10.1007/s00394-021-02772-0
|
| 88 |
Rabab Fouad Emam, Ahmed Fouad Soliman, Samar Kamal Darweesh, Reham AbdElmoniem AbdElmagid, Ola Mohamed Ibrahim, Dina Mahmoud Mohamed. Steatosis regression assessed by cap after Vitamin ‘D’ supplementation in NAFLD patients with Vitamin ‘D’ deficiency. European Journal of Gastroenterology & Hepatology 2024; 36(1): 101 doi: 10.1097/MEG.0000000000002653
|
| 89 |
Mariana B. Tablas, Renata L. Goto, Brunno F. R. Caetano, Sérgio A. A. dos Santos, Luis F. Barbisan. Vitamin D3 suppresses the early stages of chemically induced hepatocarcinogenesis in rats: a dose-response analysis. Nutrire 2018; 43(1) doi: 10.1186/s41110-018-0065-2
|
| 90 |
Meng Yang, Feng Ma, Min Guan. Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Metabolites 2021; 11(5): 320 doi: 10.3390/metabo11050320
|
| 91 |
Alia S Dadabhai, Behnam Saberi, Katie Lobner, Russell T Shinohara, Gerard E Mullin. Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data. World Journal of Hepatology 2017; 9(5): 278-287 doi: 10.4254/wjh.v9.i5.278
|
| 92 |
Felice Cinque, Annalisa Cespiati, Rosa Lombardi, Giovanni Guaraldi, Giada Sebastiani. Nutritional and Lifestyle Therapy for NAFLD in People with HIV. Nutrients 2023; 15(8): 1990 doi: 10.3390/nu15081990
|
| 93 |
Harry G. Preuss, Gilbert R. Kaats, Nate Mrvichin, Debasis Bagchi, Rich Scheckenbach. Correlating Circulating Vitamin D3 with Aspects of the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Healthy Female Volunteers. Journal of the American College of Nutrition 2020; 39(7): 585 doi: 10.1080/07315724.2020.1774940
|
| 94 |
Vishal Sarsani, Sarah M. Brotman, Yin Xianyong, Lillian Fernandes Silva, Markku Laakso, Cassandra N. Spracklen. A cross-ancestry genome-wide meta-analysis, fine-mapping, and gene prioritization approach to characterize the genetic architecture of adiponectin. Human Genetics and Genomics Advances 2024; 5(1): 100252 doi: 10.1016/j.xhgg.2023.100252
|
| 95 |
Tadej Rondaij, Nada Rotovnik Kozjek, Peter Popovič, Taja Jordan. Vitamin D deficiency in patients with chronic intestinal failure on home parenteral nutrition. Clinical Nutrition ESPEN 2021; 42: 258 doi: 10.1016/j.clnesp.2021.01.026
|
| 96 |
Goran Bjelakovic, Dimitrinka Nikolova, Marko Bjelakovic, Christian Gluud. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database of Systematic Reviews 2017; 2017(11) doi: 10.1002/14651858.CD011564.pub2
|
| 97 |
Milica Bjelakovic, Dimitrinka Nikolova, Goran Bjelakovic, Christian Gluud. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database of Systematic Reviews 2021; 2021(10) doi: 10.1002/14651858.CD011564.pub3
|
| 98 |
Shuai Yuan, Susanna C. Larsson. Inverse Association Between Serum 25-Hydroxyvitamin D and Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology 2023; 21(2): 398 doi: 10.1016/j.cgh.2022.01.021
|
| 99 |
Yahav Eilam, Noam Pintel, Hamdan Khattib, Natalie Shagug, Raged Taha, Dorit Avni. Regulation of Cholesterol Metabolism by Phytochemicals Derived from Algae and Edible Mushrooms in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(22): 13667 doi: 10.3390/ijms232213667
|
| 100 |
Hany Haroun Kaisar, Ahmed Samir Abo Halima. Association of vitamin D supplementation with serum leptin and metabolic parameters in Egyptian patients with non-alcoholic steatohepatitis: a prospective study. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00049-5
|
| 101 |
Erica Jennison, Christopher D. Byrne. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Clinical and Molecular Hepatology 2021; 27(1): 22 doi: 10.3350/cmh.2020.0129
|
| 102 |
L. A. Suplotova, V. A. Avdeeva, L. Y. Rozhinskaya. To the question of the pathogenetic mechanisms of the influence of obesity on the level of vitamin D. Obesity and metabolism 2021; 18(2): 169 doi: 10.14341/omet12578
|
| 103 |
Nasser M. Al-Daghri, Sobhy M. Yakout, Mohammed G.A. Ansari, Syed D. Hussain, Kaiser A. Wani, Shaun Sabico. Vitamin D Metabolites and Sex Steroid Indices in Postmenopausal Women with and without Low Bone Mass. Metabolites 2021; 11(2): 86 doi: 10.3390/metabo11020086
|
| 104 |
Mustafa Younis Gaballah Younis. Prevalence of vitamin D deficiency in Libya and its relation to other health disorders. Metabolism and Target Organ Damage 2024; doi: 10.20517/mtod.2023.36
|
| 105 |
Yasunobu Yoshida, Jun-ichi Furukawa, Shoichi Naito, Kenichi Higashino, Yoshito Numata, Yasuro Shinohara. Identification of unique glycoisoforms of vitamin D-binding protein and haptoglobin as biomarker candidates in hepatocarcinogenesis of STAM mice. Glycoconjugate Journal 2018; 35(5): 467 doi: 10.1007/s10719-018-9838-3
|
| 106 |
Zhiguo Miao, Shan Wang, Yimin Wang, Liping Guo, Jinzhou Zhang, Yang Liu, Qiyuan Yang. A Potential Linking between Vitamin D and Adipose Metabolic Disorders. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/2656321
|
| 107 |
Louise Wamberg, Steen B. Pedersen, Lars Rejnmark, Bjørn Richelsen. Causes of Vitamin D Deficiency and Effect of Vitamin D Supplementation on Metabolic Complications in Obesity: a Review. Current Obesity Reports 2015; 4(4): 429 doi: 10.1007/s13679-015-0176-5
|
| 108 |
Nicole Haroun, Imene Bennour, Eva Seipelt, Julien Astier, Léa Sani, Catherine Tardivel, Ljubica Svilar, Jean‐Charles Martin, Lourdes Mounien, Jean François Landrier. Maternal Vitamin D Deficiency in Mice Sex‐Dependently Affects Hepatic Lipid Accumulation in Offspring. Molecular Nutrition & Food Research 2024; 68(1) doi: 10.1002/mnfr.202300290
|
| 109 |
Ryan Giblin, Ellen Bennett, Graeme Zosky, Renée Dwyer. The Impact of Sex and 25(OH)D Deficiency on Metabolic Function in Mice. Nutrients 2017; 9(9): 985 doi: 10.3390/nu9090985
|
| 110 |
R.B. Prussick, L. Miele. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?. British Journal of Dermatology 2018; 179(1): 16 doi: 10.1111/bjd.16239
|
| 111 |
Najeff Waseem, Berkeley N. Limketkai, Brian Kim, Tinsay Woreta, Ahmet Gurakar, Po-Hung Chen. Risk and Prognosis of Acute Liver Injury Among Hospitalized Patients with Hemodynamic Instability: A Nationwide Analysis. Annals of Hepatology 2018; 17(1): 119 doi: 10.5604/01.3001.0010.7543
|
| 112 |
Tannaz Jamialahmadi, Mohsen Nematy, Mohammed Abdalla, Ali Jangjoo, Ladan Goshayeshi, Matthew Kroh, Seyed Adel Moallem, Mitra Abbasifard, Thozhukat Sathyapalan, Amirhossein Sahebkar, Roxana Valdés-Ramos. The Predictive Role of Parathyroid Hormone for Nonalcoholic Fatty Liver Disease following Bariatric Surgery. Journal of Nutrition and Metabolism 2022; 2022: 1 doi: 10.1155/2022/7319742
|
| 113 |
Vahid Sheikhi, Zahra Heidari. Low Vitamin D Level was Associated with Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Shiraz E-Medical Journal 2021; 23(3) doi: 10.5812/semj.118125
|
| 114 |
Veeravich Jaruvongvanich, Wasin Ahuja, Anawin Sanguankeo, Karn Wijarnpreecha, Sikarin Upala. Vitamin D and histologic severity of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Digestive and Liver Disease 2017; 49(6): 618 doi: 10.1016/j.dld.2017.02.003
|